Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia

Introduction: Hypophosphatemia occurs commonly in inflammatory bowel disease (IBD) patients and can cause considerable morbidity. The differential diagnoses in IBD include nutritional causes and hypophosphatemia induced by some formulations of intravenous iron infusions. Case Presentation: We presen...

Full description

Bibliographic Details
Main Authors: Kate Hawke, Anthony Croft, Syndia Lazarus
Format: Article
Language:English
Published: Karger Publishers 2024-02-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:https://beta.karger.com/Article/FullText/536136
_version_ 1827312276632240128
author Kate Hawke
Anthony Croft
Syndia Lazarus
author_facet Kate Hawke
Anthony Croft
Syndia Lazarus
author_sort Kate Hawke
collection DOAJ
description Introduction: Hypophosphatemia occurs commonly in inflammatory bowel disease (IBD) patients and can cause considerable morbidity. The differential diagnoses in IBD include nutritional causes and hypophosphatemia induced by some formulations of intravenous iron infusions. Case Presentation: We present the case of a 37-year-old man with active Crohn’s disease, presenting with difficulty walking and fractures of the vertebrae and calcaneus. He had long-standing hypophosphatemia. Nutritional causes for hypophosphatemia were considered in the first instance given the presence of chronic diarrhea and vitamin D deficiency; however, there was minimal response to appropriate supplementation with oral phosphorous and vitamin D. Iron infusion-induced hypophosphatemia was then considered, but the nadir phosphate level preceded any iron infusion. Therefore, work-up was undertaken for less common causes. He was ultimately diagnosed with tumor-induced osteomalacia, caused by excess fibroblast growth factor 23 (FGF23) secretion from a phosphaturic mesenchymal tumor about the knee. He had complete resolution of symptoms and biochemical abnormalities following successful resection of the tumor. Conclusion: This case illustrates the approach to investigation of hypophosphatemia in IBD patients. If the time course and response to phosphate supplementation are not as expected for nutritional or iron infusion-induced hypophosphatemia, less common causes should be considered.
first_indexed 2024-03-07T19:39:24Z
format Article
id doaj.art-51cd73910f4843538482d69e92695e99
institution Directory Open Access Journal
issn 1662-0631
language English
last_indexed 2024-04-24T21:39:19Z
publishDate 2024-02-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj.art-51cd73910f4843538482d69e92695e992024-03-21T08:27:29ZengKarger PublishersCase Reports in Gastroenterology1662-06312024-02-01181818910.1159/000536136536136Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating HypophosphatemiaKate Hawke0Anthony Croft1Syndia Lazarus2Department of Diabetes and Endocrinology, Royal Brisbane and Women’s Hospital, Herston, QLD, AustraliaFaculty of Medicine, University of Queensland, Brisbane, QLD, AustraliaDepartment of Diabetes and Endocrinology, Royal Brisbane and Women’s Hospital, Herston, QLD, AustraliaIntroduction: Hypophosphatemia occurs commonly in inflammatory bowel disease (IBD) patients and can cause considerable morbidity. The differential diagnoses in IBD include nutritional causes and hypophosphatemia induced by some formulations of intravenous iron infusions. Case Presentation: We present the case of a 37-year-old man with active Crohn’s disease, presenting with difficulty walking and fractures of the vertebrae and calcaneus. He had long-standing hypophosphatemia. Nutritional causes for hypophosphatemia were considered in the first instance given the presence of chronic diarrhea and vitamin D deficiency; however, there was minimal response to appropriate supplementation with oral phosphorous and vitamin D. Iron infusion-induced hypophosphatemia was then considered, but the nadir phosphate level preceded any iron infusion. Therefore, work-up was undertaken for less common causes. He was ultimately diagnosed with tumor-induced osteomalacia, caused by excess fibroblast growth factor 23 (FGF23) secretion from a phosphaturic mesenchymal tumor about the knee. He had complete resolution of symptoms and biochemical abnormalities following successful resection of the tumor. Conclusion: This case illustrates the approach to investigation of hypophosphatemia in IBD patients. If the time course and response to phosphate supplementation are not as expected for nutritional or iron infusion-induced hypophosphatemia, less common causes should be considered.https://beta.karger.com/Article/FullText/536136hypophosphatemiainflammatory bowel diseasescrohn’s diseasemetabolic bone diseasescase report
spellingShingle Kate Hawke
Anthony Croft
Syndia Lazarus
Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
Case Reports in Gastroenterology
hypophosphatemia
inflammatory bowel diseases
crohn’s disease
metabolic bone diseases
case report
title Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
title_full Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
title_fullStr Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
title_full_unstemmed Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
title_short Tumor-Induced Osteomalacia in a Patient with Crohn’s Disease: A Case Report and Approach to Investigating Hypophosphatemia
title_sort tumor induced osteomalacia in a patient with crohn s disease a case report and approach to investigating hypophosphatemia
topic hypophosphatemia
inflammatory bowel diseases
crohn’s disease
metabolic bone diseases
case report
url https://beta.karger.com/Article/FullText/536136
work_keys_str_mv AT katehawke tumorinducedosteomalaciainapatientwithcrohnsdiseaseacasereportandapproachtoinvestigatinghypophosphatemia
AT anthonycroft tumorinducedosteomalaciainapatientwithcrohnsdiseaseacasereportandapproachtoinvestigatinghypophosphatemia
AT syndialazarus tumorinducedosteomalaciainapatientwithcrohnsdiseaseacasereportandapproachtoinvestigatinghypophosphatemia